Biostem COO Smith-Van Vurst buys 250,000 shares (Form 4)
Biostem Technologies COO Andrew Smith-Van Vurst reported acquiring 250,000 shares at $2.00 each in a Form 4 transaction dated 10/7/26.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.